Author:
Gay F,Oliva S,Petrucci M T,Montefusco V,Conticello C,Musto P,Catalano L,Evangelista A,Spada S,Campbell P,Ria R,Salvini M,Offidani M,Carella A M,Omedé P,Liberati A M,Troia R,Cafro A M,Malfitano A,Falcone A P,Caravita T,Patriarca F,Nagler A,Spencer A,Hajek R,Palumbo A,Boccadoro M
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference36 articles.
1. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF et al SEER cancer statistics review, 1975–2010. Bethesda, MD, USA: National Cancer Institute, based on November 2012 SEER data submission, posted to the SEER Web site, 2013. Available at http://seer.cancer.gov/csr/1975_2010/.
2. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516–2520.
3. Ludwig H, Sonneveld P, Davies F, Bladé J, Boccadoro M, Cavo M et al. European perspective on multiple myeloma treatment strategies in 2014. Oncologist 2014; 19: 829–844.
4. Moreau P, Attal M, Facon T . Frontline therapy of multiple myeloma. Blood 2015; 125: 3076–3084.
5. Fayers PM, Palumbo A, Hulin C, Waage A, Wijermans P, Beksaç M et al. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials. Blood 2011; 118: 1239–1247.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献